Inventor · disambiguated record
Yifan Zhai
Also filed as: ZHAI YIFAN
35 granted patents·32 pending applications·154 citations·filing 1999–2025
96Inventor score
Files withASCENTAGE PHARMA SUZHOU CO LTD41JINGNING MEIGE TECH SERVICE CO LTD14HUMAN GENOME SCIENCES INC4CARTER CHRISTOPHER A2JIANGSU ASCENTAGE BIOMED DEV INC2
Top patents by PatentIndex Score
67 records- 0194US12304692B1Storage boxJINGNING MEIGE TECH SERVICE CO LTD·Filed 2024·Granted May 20, 2025·3 cites·20 claims
- 0294US11850239B2MDM2 inhibitor and a platinum compound for cancer treatmentASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Granted Dec 26, 2023·3 cites·20 claims
- 0394US6635743B1Apoptosis inducing molecule II and methods of useHUMAN GENOME SCIENCES INC·Filed 2000·Granted Oct 21, 2003·60 cites·39 claims
- 0492USD1082050SStorage shedMYEAGLE PTE LTD·Filed 2025·Granted Jul 1, 2025·2 cites·1 claims
- 0591USD1020279SGaming chairJINGNING MEIGE TECH SERVICE CO LTD·Filed 2024·Granted Apr 2, 2024·12 cites·1 claims
- 0690USD1047433SStorage boxJINGNING MEIGE TECH SERVICE CO LTD·Filed 2024·Granted Oct 22, 2024·11 cites·1 claims
- 0790USD1012494SStorage boxJINGNING MEIGE TECH SERVICE CO LTD·Filed 2023·Granted Jan 30, 2024·12 cites·1 claims
- 0890US11452716B2Pharmaceutical composition and use thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Granted Sep 27, 2022·3 cites·20 claims
- 0987USD1048773SStorage boxJINGNING MEIGE TECH SERVICE CO LTD·Filed 2024·Granted Oct 29, 2024·8 cites·1 claims
- 1085USD1044350SCabinetJINGNING MEIGE TECH SERVICE CO LTD·Filed 2024·Granted Oct 1, 2024·7 cites·1 claims
- 1183US11478469B2Combination product of BCL-2 inhibitor and MDM2 inhibitor and use thereof in the prevention and/or treatment of diseasesASCENTAGE PHARMA SUZHOU CO LTD·Filed 2019·Granted Oct 25, 2022·2 cites·10 claims
- 1278US12268665B2Combination of immunotherapies with MDM2 inhibitorsASCENTAGE PHARMA SUZHOU CO LTD·Filed 2019·Granted Apr 8, 2025·1 cites·13 claims
- 1378US11395815B2Compound for treating osteoarthritisASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Granted Jul 26, 2022·1 cites·14 claims
- 1474USD1053560SStorage boxJINGNING MEIGE TECH SERVICE CO LTD·Filed 2024·Granted Dec 10, 2024·3 cites·1 claims
- 1573US11298339B2Bisdiazabicyclo compound for treatment and/or prevention of hepatitis virus-related diseases or disordersJIANGSU ASCENTAGE BIOMED DEV INC·Filed 2018·Granted Apr 12, 2022·1 cites·5 claims
- 1672USD1021440SRattan chairJINGNING MEIGE TECH SERVICE CO LTD·Filed 2024·Granted Apr 9, 2024·3 cites·1 claims
- 1772US7964190B2Methods and compositions for decreasing T-cell activityHUMAN GENOME SCIENCES INC·Filed 2003·Granted Jun 21, 2011·3 cites·12 claims
- 1872US2024390401A1Combination of bcl-2/bcl-xl inhibitors and chemotherapeutic agent and use thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2024·Application pending·0 cites
- 1969USD1097427SStorage shedJINGNING MEIGE TECH SERVICE CO LTD·Filed 2024·Granted Oct 7, 2025·2 cites·1 claims
- 2068USD1054590SOutdoor screenJINGNING MEIGE TECH SERVICE CO LTD·Filed 2024·Granted Dec 17, 2024·2 cites·1 claims
- 2167US12083136B2Combination of BCL-2/BCL-XL inhibitors and chemotherapeutic agent and use thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2019·Granted Sep 10, 2024·0 cites·4 claims
- 2266USD1058193SCombined storage box and seatJINGNING MEIGE TECH SERVICE CO LTD·Filed 2024·Granted Jan 21, 2025·2 cites·1 claims
- 2364US2025281511A1N-(phenylsulfonyl)benzamides and related compounds as bcl-2 inhibitorsASCENTAGE PHARMA SUZHOU CO LTD·Filed 2025·Application pending·0 cites
- 2463US12370197B2Combination product of a Bcl-2/Bcl-xL inhibitor and a chemotherapeutic agent and use thereof in the prevention and/or treatment of diseasesASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Granted Jul 29, 2025·0 cites·8 claims
- 2563USD1069171SStorage shedJINGNING MEIGE TECH SERVICE CO LTD·Filed 2024·Granted Apr 1, 2025·1 cites·1 claims
- 2663US12233047B2Pharmaceutical combination and use thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Granted Feb 25, 2025·0 cites·20 claims
- 2763US2025152580A1Methods for treating immune diseasesASCENTAGE PHARMA SUZHOU CO LTD·Filed 2023·Application pending·0 cites
- 2863US2022193071A1Methods for cancer therapyASCENTAGE PHARMA SUZHOU CO LTD·Filed 2019·Application pending·0 cites
- 2962US12343352B2N-(phenylsulfonyl)benzamides and related compounds as Bcl-2 inhibitorsASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Granted Jul 1, 2025·0 cites·12 claims
- 3062US11491167B2Combination product of Bcl-2 inhibitor and chemotherapeutic agent and use thereof in the prevention and/or treatment of diseasesASCENTAGE PHARMA SUZHOU CO LTD·Filed 2019·Granted Nov 8, 2022·0 cites·11 claims
- 3162US2022296571A1Bisdiazabicyclo compound for treating and/or preventing hepatitis virus-related diseases or disordersJIANGSU ASCENTAGE BIOMED DEV INC·Filed 2022·Application pending·0 cites
- 3260US2023404998A1Combination Therapies for Treating CancerASCENTAGE PHARMA SUZHOU CO LTD·Filed 2023·Application pending·0 cites
- 3360US2025114329A1Methods for treating aml-mrc and mdsASCENTAGE PHARMA SUZHOU CO LTD·Filed 2023·Application pending·0 cites
- 3459US11554127B2Synergistic antitumor effect of Bcl-2 inhibitor combined with rituximab and/or bendamustine or Bcl-2 inhibitor combined with CHOPASCENTAGE PHARMA SUZHOU CO LTD·Filed 2019·Granted Jan 17, 2023·0 cites·12 claims
- 3559US2006247186A1Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancersCARTER CHRISTOPHER A·Filed 2006·Application pending·0 cites
- 3659US2025099440A1A pharmaceutical combination and use thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 3757US2025235426A1Pharmaceutical Combination and Use ThereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2025·Application pending·0 cites
- 3857US2024316051A1A pharmaceutical combination and use thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 3957US2024366611A1Methods of treating a disease or disorderASCENTAGE PHARMA SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 4056US2024316069A1Methods of treating multiple sclerosisASCENTAGE PHARMA SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 4156US2023381176A1A pharmaceutical composition and use thereof for treatment of cancerASCENTAGE PHARMA SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 4256US2023398110A1Compositions and methods for treating non-alcoholic steatohepatitisASCENTAGE PHARMA SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 4355US2023149356A1Novel medical use of mdm2 inhibitorsASCENTAGE PHARMA SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 4454US12287338B2Method and compositions for predicting anti-cancer efficacy of compounds targeting apoptosis pathwayASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Granted Apr 29, 2025·0 cites·12 claims
- 4554US2023301989A1Compositions and methods for treating systemic lupus erythematosusASCENTAGE PHARMA SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 4654US2023078120A1Methods for Treating Coronavirus InfectionsASCENTAGE PHARMA SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 4754US2022296557A1Combinations of bcl-2/bcl-xl inhibitors and related usesASCENTAGE PHARMA SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 4854US2003232765A1Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancersBAYER AG·Filed 2002·Application pending·0 cites
- 4953US2021275522A1Pharmaceutical compositions and use thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2019·Application pending·0 cites
- 5052US12194024B2Pharmaceutical composition of MDM2 inhibitor and use thereof for preventing and/or treating diseaseASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Granted Jan 14, 2025·0 cites·5 claims
Showing the top 50 of 67 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Yifan Zhai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →